Inogen Company Leadership
INGN Stock | USD 6.90 0.20 2.99% |
Inogen's insiders are aggressively selling. The analysis of insiders' sentiment of trading Inogen Inc stock suggests that virtually all insiders are panicking at this time. Inogen employs about 834 people. The company is managed by 27 executives with a total tenure of roughly 121 years, averaging almost 4.0 years of service per executive, having 30.89 employees per reported executive.
Raymond Huggenberger CEO CEO and Director |
Heath Lukatch Chairman Independent Chairman of the Board |
Inogen's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2022-03-03 | Ray Benjamin M Anderson | Disposed 4516 @ 34.68 | View | ||
2021-08-16 | Raymond Huggenberger | Disposed 6594 @ 62.69 | View | ||
2021-08-02 | Alison Bauerlein | Disposed 1397 @ 80.33 | View | ||
2021-07-30 | Alison Bauerlein | Disposed 8235 @ 80.01 | View | ||
2021-07-27 | Brenton Taylor | Disposed 7942 @ 75.02 | View | ||
2021-07-15 | Raymond Huggenberger | Disposed 7000 @ 65.83 | View | ||
2021-06-15 | Raymond Huggenberger | Disposed 7087 @ 63.81 | View | ||
2021-06-02 | Holdings A/S Novo | Disposed 680000 @ 57.32 | View |
Monitoring Inogen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Inogen |
Inogen's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Inogen's future performance. Based on our forecasts, it is anticipated that Inogen will maintain a workforce of about 830 employees by May 2024.Inogen's latest congressional trading
Congressional trading in companies like Inogen Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Inogen by those in governmental positions are based on the same information available to the general public.
2018-11-20 | Representative Lamar Smith | Acquired Under $15K | Verify |
Inogen Management Team Effectiveness
The company has return on total asset (ROA) of (0.1091) % which means that it has lost $0.1091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.408) %, meaning that it created substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to -0.35. In addition to that, Return On Capital Employed is likely to grow to -0.24. At this time, Inogen's Deferred Long Term Asset Charges is very stable compared to the past year. As of the 23rd of April 2024, Intangibles To Total Assets is likely to grow to 0.14, while Total Assets are likely to drop about 292 M.As of the 23rd of April 2024, Common Stock Shares Outstanding is likely to drop to about 22.7 M. In addition to that, Net Loss is likely to grow to about (71.6 M)
Inogen Workforce Comparison
Inogen Inc is rated fifth overall in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 7,724. Inogen retains roughly 834 in number of employees claiming about 11% of equities under Health Care industry.
Inogen Profit Margins
The company has Profit Margin (PM) of (0.32) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.53 | 0.4326 |
|
|
Inogen Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Inogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.75 | 6 | 8 | 247,053 | 33,263 |
2023-12-01 | 0.3333 | 2 | 6 | 5,131 | 92,748 |
2023-09-01 | 0.4286 | 3 | 7 | 5,032 | 7,655 |
2023-06-01 | 1.2222 | 11 | 9 | 110,431 | 9,274 |
2023-03-01 | 0.6667 | 16 | 24 | 225,500 | 71,663 |
2022-12-01 | 0.3846 | 5 | 13 | 10,450 | 15,712 |
2022-09-01 | 0.1111 | 1 | 9 | 3,075 | 11,150 |
2022-06-01 | 2.0 | 12 | 6 | 266,750 | 10,998 |
2022-03-01 | 1.5 | 12 | 8 | 141,722 | 45,220 |
2021-12-01 | 0.5 | 2 | 4 | 819.00 | 1,534 |
2021-09-01 | 0.5714 | 16 | 28 | 81,611 | 110,076 |
2021-06-01 | 0.8214 | 23 | 28 | 62,654 | 727,685 |
2021-03-01 | 0.5882 | 30 | 51 | 297,778 | 1,156,284 |
2020-12-01 | 0.1818 | 4 | 22 | 17,910 | 36,550 |
2020-09-01 | 0.2143 | 3 | 14 | 22,115 | 1,739 |
2020-06-01 | 0.5714 | 8 | 14 | 27,746 | 1,731 |
2020-03-01 | 0.5 | 7 | 14 | 44,190 | 3,751 |
2019-12-01 | 0.2222 | 2 | 9 | 504.00 | 1,244 |
2019-09-01 | 0.6 | 6 | 10 | 7,506 | 5,110 |
2019-06-01 | 1.875 | 15 | 8 | 32,776 | 1,104 |
2019-03-01 | 0.8571 | 24 | 28 | 52,212 | 25,009 |
2018-12-01 | 0.3818 | 21 | 55 | 89,426 | 129,644 |
2018-09-01 | 0.2748 | 36 | 131 | 111,159 | 234,816 |
2018-06-01 | 0.44 | 22 | 50 | 54,888 | 107,054 |
2018-03-01 | 0.4405 | 37 | 84 | 178,405 | 336,966 |
2017-12-01 | 0.4792 | 23 | 48 | 97,333 | 209,713 |
2017-09-01 | 0.6944 | 25 | 36 | 90,832 | 138,667 |
2017-06-01 | 0.5714 | 24 | 42 | 169,277 | 190,560 |
2017-03-01 | 0.3171 | 13 | 41 | 103,057 | 233,940 |
2016-12-01 | 0.4167 | 10 | 24 | 60,050 | 122,729 |
2016-09-01 | 0.4 | 12 | 30 | 92,485 | 197,970 |
2016-06-01 | 0.9583 | 23 | 24 | 575,067 | 241,916 |
2016-03-01 | 0.4444 | 8 | 18 | 69,150 | 86,364 |
2015-12-01 | 0.4848 | 16 | 33 | 231,473 | 313,778 |
2015-09-01 | 0.42 | 21 | 50 | 206,646 | 406,414 |
2015-06-01 | 0.1818 | 6 | 33 | 387,500 | 741,534 |
2015-03-01 | 0.5079 | 32 | 63 | 601,001 | 2,992,244 |
2014-12-01 | 0.7821 | 122 | 156 | 1,440,695 | 8,519,837 |
2014-09-01 | 0.087 | 10 | 115 | 101,295 | 1,190,593 |
2014-06-01 | 2.7143 | 19 | 7 | 575,021 | 50,544 |
2014-03-01 | 0.4578 | 38 | 83 | 22,529,043 | 18,868,060 |
2008-06-01 | 2.0 | 4 | 2 | 705,000 | 74,000 |
2007-03-01 | 1.0 | 2 | 2 | 102,400 | 83,200 |
2003-09-01 | 5.0 | 5 | 1 | 112,350 | 5,500 |
Inogen Notable Stakeholders
An Inogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Inogen often face trade-offs trying to please all of them. Inogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Inogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
About Inogen Management Performance
The success or failure of an entity such as Inogen Inc often depends on how effective the management is. Inogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.36) | (0.35) | |
Return On Capital Employed | (0.25) | (0.24) | |
Return On Assets | (0.31) | (0.30) | |
Return On Equity | (0.50) | (0.48) |
The data published in Inogen's official financial statements usually reflect Inogen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Inogen Inc. For example, before you start analyzing numbers published by Inogen accountants, it's critical to develop an understanding of what Inogen's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Inogen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inogen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Inogen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inogen Inc. Please utilize our Beneish M Score to check the likelihood of Inogen's management manipulating its earnings.
Inogen Workforce Analysis
Traditionally, organizations such as Inogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Inogen within its industry.Inogen Manpower Efficiency
Return on Inogen Manpower
Revenue Per Employee | 378.5K | |
Revenue Per Executive | 11.7M | |
Net Loss Per Employee | 122.8K | |
Net Loss Per Executive | 3.8M | |
Working Capital Per Employee | 161.4K | |
Working Capital Per Executive | 5M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Inogen Inc information on this page should be used as a complementary analysis to other Inogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Inogen Stock analysis
When running Inogen's price analysis, check to measure Inogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inogen is operating at the current time. Most of Inogen's value examination focuses on studying past and present price action to predict the probability of Inogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inogen's price. Additionally, you may evaluate how the addition of Inogen to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Inogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (4.42) | Revenue Per Share 13.62 | Quarterly Revenue Growth (0.14) | Return On Assets (0.11) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.